Last Updated: May 30, 2026

Mylan Labs Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for MYLAN LABS

MYLAN LABS has sixty-five approved drugs.

There are nine tentative approvals on MYLAN LABS drugs.

Summary for Mylan Labs
US Patents:0
Tradenames:52
Ingredients:51
NDAs:65

Drugs and US Patents for Mylan Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd ESMOLOL HYDROCHLORIDE esmolol hydrochloride INJECTABLE;INJECTION 206608-002 Jun 8, 2018 AP RX No No ⤷  Start Trial ⤷  Start Trial
Mylan Labs Ltd DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 075375-001 Sep 30, 1999 DISCN No No ⤷  Start Trial ⤷  Start Trial
Mylan Labs Ltd PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 210710-001 Oct 25, 2018 AP RX No No ⤷  Start Trial ⤷  Start Trial
Mylan Labs Ltd IRON SUCROSE iron sucrose INJECTABLE;INTRAVENOUS 212559-002 Aug 8, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.